Clinical Trial Update: R(+) Pramipexole in Early Amyotrophic Lateral Sclerosis [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluating R(+) Pramipexole in patients with early amyotrophic lateral sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• R(+) Pramipexole (pramipexole)

Snippet

Sponsor: Bennett, James P., Jr., M.D., Ph.D. | Conditions: Amyotrophic Lateral Sclerosis | Phase 1, Phase 2 | Status: COMPLETED